SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001206774-18-001345
Filing Date
2018-04-24
Accepted
2018-04-24 16:30:58
Documents
7
Effectiveness Date
2018-04-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS bmrn3334561-defa14a.htm DEFA14A 36291
2 GRAPHIC bmrn3334561-defa14alogo.jpg GRAPHIC 9164
3 GRAPHIC bmrn3334561-defa14ax1x1.jpg GRAPHIC 8456
4 GRAPHIC bmrn3334561-defa14ax1x2.jpg GRAPHIC 2823
5 GRAPHIC bmrn3334561-defa14ax2x1.jpg GRAPHIC 2562
6 GRAPHIC bmrn3334561-defa14ax3x1.jpg GRAPHIC 2772
7 GRAPHIC bmrn3334561-defa14ax4x1.jpg GRAPHIC 2804
  Complete submission text file 0001206774-18-001345.txt   77616
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26727 | Film No.: 18771764
SIC: 2834 Pharmaceutical Preparations